Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transcat (TRNS) Liabilities and Shareholders Equity (2019 - 2025)

Transcat's Liabilities and Shareholders Equity history spans 11 years, with the latest figure at $472.9 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 22.51% year-over-year to $472.9 million; the TTM value through Dec 2025 reached $1.7 billion, up 31.41%, while the annual FY2025 figure was $385.2 million, 33.97% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $472.9 million at Transcat, down from $484.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $484.9 million in Q3 2025 and bottomed at $131.1 million in Q2 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $225.8 million (2023), against an average of $265.1 million.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 5.62% in 2021 before it soared 59.18% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $161.6 million in 2021, then rose by 16.63% to $188.5 million in 2022, then skyrocketed by 49.14% to $281.1 million in 2023, then surged by 37.33% to $386.0 million in 2024, then grew by 22.51% to $472.9 million in 2025.
  • Per Business Quant, the three most recent readings for TRNS's Liabilities and Shareholders Equity are $472.9 million (Q4 2025), $484.9 million (Q3 2025), and $392.5 million (Q2 2025).